annual operating expenses:
$501.88M-$25.35M(-4.81%)Summary
- As of today (September 10, 2025), DNLI annual total operating expenses is $501.88 million, with the most recent change of -$25.35 million (-4.81%) on December 31, 2024.
- During the last 3 years, DNLI annual operating expenses has risen by +$157.47 million (+45.72%).
- DNLI annual operating expenses is now -4.81% below its all-time high of $527.23 million, reached on December 31, 2023.
Performance
DNLI Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$131.92M-$11.34M(-7.91%)Summary
- As of today (September 10, 2025), DNLI quarterly total operating expenses is $131.92 million, with the most recent change of -$11.34 million (-7.91%) on June 30, 2025.
- Over the past year, DNLI quarterly operating expenses has increased by +$17.27 million (+15.06%).
- DNLI quarterly operating expenses is now -10.13% below its all-time high of $146.79 million, reached on March 31, 2023.
Performance
DNLI quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
DNLI Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.8% | +15.1% |
| 3 y3 years | +45.7% | +17.1% |
| 5 y5 years | +109.2% | +115.3% |
DNLI Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -4.8% | +45.7% | -10.1% | +20.2% |
| 5 y | 5-year | -4.8% | +109.2% | -10.1% | +154.1% |
| alltime | all time | -4.8% | +2909.0% | -10.1% | +154.1% |
DNLI Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $131.92M(-7.9%) |
| Mar 2025 | - | $143.25M(+11.9%) |
| Dec 2024 | $501.88M(-4.8%) | $127.99M(+5.5%) |
| Sep 2024 | - | $121.35M(+5.8%) |
| Jun 2024 | - | $114.65M(-11.9%) |
| Mar 2024 | - | $130.09M(-0.2%) |
| Dec 2023 | $527.23M(+17.4%) | $130.40M(+15.6%) |
| Sep 2023 | - | $112.84M(-7.7%) |
| Jun 2023 | - | $122.28M(-16.7%) |
| Mar 2023 | - | $146.79M(+30.6%) |
| Dec 2022 | $449.21M(+30.4%) | $112.40M(+2.4%) |
| Sep 2022 | - | $109.77M(-2.6%) |
| Jun 2022 | - | $112.66M(+5.0%) |
| Mar 2022 | - | $107.34M(+21.5%) |
| Dec 2021 | $344.41M(+26.2%) | $88.32M(+3.2%) |
| Sep 2021 | - | $85.59M(+38.5%) |
| Jun 2021 | - | $61.82M(-13.2%) |
| Mar 2021 | - | $71.22M(-129.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $272.94M(+13.8%) | -$244.08M(-506.0%) |
| Sep 2020 | - | $60.12M(-1.9%) |
| Jun 2020 | - | $61.28M(+2.2%) |
| Mar 2020 | - | $59.97M(+3.8%) |
| Dec 2019 | $239.86M(+36.6%) | $57.76M(+15.2%) |
| Sep 2019 | - | $50.16M(-17.7%) |
| Jun 2019 | - | $60.96M(+43.4%) |
| Mar 2019 | - | $42.51M(-12.5%) |
| Dec 2018 | $175.53M(+94.7%) | $48.58M(+31.9%) |
| Sep 2018 | - | $36.83M(-25.8%) |
| Jun 2018 | - | $49.63M(+94.4%) |
| Mar 2018 | - | $25.54M(+12.3%) |
| Dec 2017 | $90.14M(+3.1%) | $22.73M(+5.7%) |
| Sep 2017 | - | $21.51M(-4.7%) |
| Jun 2017 | - | $22.57M(+3.8%) |
| Mar 2017 | - | $21.74M(+13.9%) |
| Dec 2016 | $87.43M(+424.2%) | $19.09M(-37.5%) |
| Sep 2016 | - | $30.53M |
| Dec 2015 | $16.68M | - |
FAQ
- What is Denali Therapeutics Inc. annual total operating expenses?
- What is the all time high annual operating expenses for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. annual operating expenses year-on-year change?
- What is Denali Therapeutics Inc. quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Denali Therapeutics Inc.?
- What is Denali Therapeutics Inc. quarterly operating expenses year-on-year change?
What is Denali Therapeutics Inc. annual total operating expenses?
The current annual operating expenses of DNLI is $501.88M
What is the all time high annual operating expenses for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high annual total operating expenses is $527.23M
What is Denali Therapeutics Inc. annual operating expenses year-on-year change?
Over the past year, DNLI annual total operating expenses has changed by -$25.35M (-4.81%)
What is Denali Therapeutics Inc. quarterly total operating expenses?
The current quarterly operating expenses of DNLI is $131.92M
What is the all time high quarterly operating expenses for Denali Therapeutics Inc.?
Denali Therapeutics Inc. all-time high quarterly total operating expenses is $146.79M
What is Denali Therapeutics Inc. quarterly operating expenses year-on-year change?
Over the past year, DNLI quarterly total operating expenses has changed by +$17.27M (+15.06%)